Pulmonary interstitial glycogenosis in a patient with trisomy 21

A K Morrison1, M Patel2, S L Johnson3

  • 1Department of Pediatrics, University of Virginia, Charlottesville, VA, USA; (Currently Department of Pediatrics, Division of Cardiology, Nationwide Children's Hospital).

Insights

Pulmonary interstitial glycogenosis, a rare childhood lung disease, was observed in a premature infant with trisomy 21. This case highlights the association between this lung condition, Down syndrome, and heart defects.

Area of Science:

  • Pediatric Pulmonology
  • Neonatology
  • Medical Genetics

Background:

  • Pulmonary interstitial glycogenosis (PIG) is an increasingly recognized interstitial lung disease in children.
  • PIG is characterized by glycogen accumulation within interstitial cells of the lungs.
  • The etiology and specific associations of PIG are still being elucidated.

Observation:

  • A case report of a 34-week premature infant presenting with respiratory distress.
  • The infant was diagnosed with pulmonary interstitial glycogenosis.
  • Co-existing conditions included trisomy 21 (Down syndrome), pulmonary arterial hypertension, and congenital heart disease.

Findings:

  • This case demonstrates a potential association between pulmonary interstitial glycogenosis and trisomy 21.
  • The presence of pulmonary arterial hypertension and congenital heart disease in this context warrants further investigation.
  • Histopathological findings confirmed PIG in the premature infant.

Implications:

  • This case expands the known clinical spectrum associated with pulmonary interstitial glycogenosis.
  • Understanding these associations may improve diagnostic approaches and management strategies for infants with PIG, trisomy 21, and cardiac anomalies.
  • Further research is needed to explore the underlying mechanisms linking these conditions.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
995
Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...
221.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K